Last reviewed · How we verify
NCT04148105
Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
Phase 4 trial testing Cilostazol 100 MG in Aneurysmal Subarachnoid Hemorrhage in 19 participants. Terminated before completion.
21 May 2023
Quick facts
| Lead sponsor | Henry Ford Health System |
|---|---|
| Phase | Phase 4 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 19 |
| Start date | 1 November 2019 |
| Primary completion | 21 May 2023 |
| Estimated completion | 26 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cilostazol 100 MG — full drug profile →
- Placebo
Conditions studied
- Aneurysmal Subarachnoid Hemorrhage — all drugs for Aneurysmal Subarachnoid Hemorrhage →
Sponsor
Henry Ford Health System — full company profile →
Who can join
Adults 18 to 100, any sex, with Aneurysmal Subarachnoid Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators seek to demonstrate that the combined use of cilostazol and nimodipine will significantly decrease the rate of delayed cerebral infarction and cerebral vasospasm after cerebrovascular intervention when compared to nimodipine alone.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol.
Dawley T, Claus CF, Tong D, Rajamand S, et al · · 2020 · cited 5× · PMID 33020083 · DOI 10.1136/bmjopen-2019-036217
Verify or expand the search:
- PubMed search for NCT04148105
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cilostazol 100 MG
Trials testing the same drug.
- NCT06561867 — Ticagrelor Versus Cilostazol in Ischemic Stroke · Phase 3 · recruiting
- NCT06591377 — Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA · Phase 3 · recruiting
- NCT06202755 — Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke · Phase 3 · recruiting
- NCT06196047 — Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA · Phase 3 · recruiting
- NCT06242145 — Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke · Phase 3 · completed
Other recruiting trials for Aneurysmal Subarachnoid Hemorrhage
Currently open trials in the same condition.
- NCT06863480 — Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events · Phase 1 · recruiting
- NCT06409364 — FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage · Phase 2 · recruiting
- NCT06494436 — Microvention AnEurysm & STroke Real-life Data cOllection · recruiting
- NCT06548477 — Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages · NA · recruiting
- NCT06288659 — aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial · NA · recruiting
Other Henry Ford Health System trials
Trials by the same sponsor.
- NCT07450183 — Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 · Phase 2 · not yet recruiting
- NCT07418853 — Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries · NA · not yet recruiting
- NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting
- NCT07363525 — Michigan Initial Experience Using Tigertriever for Thrombectomy · not yet recruiting
- NCT07530172 — Radioembolization Versus External Radiation Therapy · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04148105 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henry Ford Health System
- Last refreshed: 31 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04148105.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing